Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
When Sarah started an antidepressant to manage her anxiety, she expected to feel better. What she didn’t expect was the emotional numbness that followed—a strange, flat sensation where she couldn’t access joy or sadness, leaving her feeling worse than before she started. Sarah’s experience reflects something many patients discover too late: there’s often a significant gap between what doctors tell you about medication and what you actually experience once you start taking it. Former patients consistently report that knowing more upfront about side effects, costs, emotional changes, and long-term commitments would have fundamentally changed their approach to treatment.
This gap in communication isn’t necessarily intentional. Doctors face a complex challenge: provide too much information about potential side effects and you risk triggering a nocebo effect—where patients’ expectations alone cause them to experience symptoms they might never have felt. Provide too little and patients feel blindsided by unexpected reactions. Understanding what former patients wish they had known before starting medication can help you enter treatment with more realistic expectations and better conversations with your healthcare provider.
Table of Contents
- What Common Side Effects Actually Feel Like in Daily Life
- The Emotional and Cognitive Changes No One Warns You About
- The Hidden Cost of Medications That Force Difficult Choices
- Understanding the Long-Term Reality of Medication Commitments
- The Paradox of Telling Patients About Side Effects
- Questions You Should Ask Your Doctor Before Starting Any Medication
- Building Your Role as an Active Participant in Your Treatment
- Conclusion
What Common Side Effects Actually Feel Like in Daily Life
Nearly one-third of patients starting GLP-1 medications for weight management reported they would have made different choices if they had truly understood how prevalent and persistent side effects would be. The most frequently reported issues weren’t rare complications—they were nausea, constipation, and gastrointestinal distress so common that many patients wonder why they weren’t better warned. For someone managing dementia care or other chronic conditions, these side effects can interact with existing medications or medical conditions in unexpected ways.
A patient caring for an aging parent while experiencing daily nausea faces a different burden than one who understands that challenge is temporary and manageable. Beyond digestive issues, hair loss emerged as a side effect many patients wish they had anticipated. Unlike nausea, which typically fades over time, hair thinning from reduced calorie intake and nutrient shifts can be psychologically distressing, and it’s not always reversible immediately when diet normalizes. One patient described looking in the mirror three months into treatment and being shocked by visible hair loss—something she felt would have influenced her decision to start the medication, or at least prompted her to monitor nutrition more carefully from day one.
The Emotional and Cognitive Changes No One Warns You About
Mental health side effects often surprise patients the most. Nearly 29% of new patients starting medications—particularly weight-loss drugs and antidepressants—reported experiencing unexpected mood swings, brain fog, or anxiety. These aren’t minor inconveniences; they directly affect quality of life and sometimes create the very symptoms patients were trying to treat. Someone starting medication to manage anxiety might instead find themselves in a fog where they can’t focus on work or their care responsibilities. The phenomenon of antidepressant-induced emotional numbness deserves particular attention.
Some patients describe it as feeling “chemically happy”—not actually happy, but anesthetized to both negative and positive emotions. They stop feeling sadness, but they also stop feeling love, joy, or excitement about life. This isn’t depression returning; it’s a different problem entirely. One patient who experienced this said she felt like she was watching her life from behind glass, present but not experiencing it. This outcome often leads to medication changes or discontinuation, but only after weeks or months of struggling with whether they’re actually getting better or worse.
The Hidden Cost of Medications That Force Difficult Choices
Cost barriers to medication adherence are often invisible until a patient stands at the pharmacy counter. According to CDC data, 8.2% of adults aged 18–64 who took prescription medications didn’t take them as prescribed specifically because of cost. That number becomes much larger when you expand it beyond “not taking as prescribed” to include people who never fill the prescription at all: approximately 21% of US adults report not filling a prescription due to cost, and 23% report using over-the-counter alternatives instead. These statistics mask individual stories of real consequences.
A person managing early cognitive decline might choose a less expensive generic when a newer medication might better suit their specific needs. Someone might skip doses to make a prescription last longer, reducing its effectiveness. Others might decide not to start treatment at all because they can’t afford the initial prescription plus potential medication adjustments if the first choice causes side effects. For families navigating dementia care on limited budgets, these decisions become especially fraught—is this the medication that truly helps, or is cost driving the choice?.
Understanding the Long-Term Reality of Medication Commitments
One of the most important revelations patients report is that many medications aren’t intended as short-term interventions. Weight-loss medications like GLP-1s and Tirzepatide (Mounjaro) illustrate this clearly: when patients discontinue these medications, weight regain typically follows. This isn’t a failure of the medication or the patient—it’s how the medication works. It manages a condition but doesn’t cure it, meaning indefinite therapy is necessary to maintain the health benefits.
Someone starting this medication needs to understand they’re entering a long-term commitment, not taking a course of treatment that ends. This reality changes cost calculations, risk-benefit analyses, and long-term planning. A patient might reasonably decide that a medication requiring indefinite use and ongoing expense isn’t aligned with their values or circumstances, but that decision should come from informed consent, not surprise. The same principle applies to many other medications used in managing cognitive and neurological conditions—understanding whether you’re treating a temporary condition or managing a chronic situation that requires ongoing medication fundamentally shapes whether treatment makes sense for your specific life circumstances.
The Paradox of Telling Patients About Side Effects
Medical research has identified something counterintuitive about how side effect information is communicated. A 2023 study in the Internal Medicine Journal found that patients’ willingness to take medication and their actual adherence was highest when they were informed of either one or four side effects—not zero side effects, and not an exhaustive list of 26 potential side effects. Too much information overwhelms patients and can paradoxically cause them to experience more symptoms simply from expecting them. This phenomenon, called the nocebo effect, is a real concern.
When patients are told extensively about potential side effects, they may begin experiencing those symptoms through a combination of heightened awareness and physiological response to expectation. However, telling patients nothing is equally problematic—they feel blindsided and lose trust in their healthcare provider when unexpected effects occur. The solution, according to experts, isn’t to withhold information but to contextualize it: a doctor should tailor side effect discussions based on the patient’s specific diagnosis, personality, and risk factors, selecting the most relevant information rather than listing everything possible. This respects patient autonomy while also reducing expectancy-induced side effects.
Questions You Should Ask Your Doctor Before Starting Any Medication
Before you start a new medication, former patients recommend asking specific questions that go beyond the standard “what are the side effects?” Your doctor should be able to explain not just what side effects are possible, but how common they actually are, when they typically appear, and what timeline to expect if they do occur. Ask whether the medication requires ongoing use or is intended as a course of treatment. Ask about cost, including whether there are generic versions or patient assistance programs available. If cost might be a barrier, say so—your doctor may have solutions you’re not aware of.
Discuss your personal risk factors for specific side effects. Someone with a history of gastrointestinal problems has different risk-benefit calculations with a GLP-1 medication than someone without such history. Someone with a family history of mood disorders needs different monitoring when starting any medication that affects neurotransmitters. Ask your doctor what symptoms should prompt you to contact them immediately versus which changes warrant waiting to see if they resolve with time. This conversation transforms medication initiation from something done to you into something done with you.
Building Your Role as an Active Participant in Your Treatment
The pattern that emerges from what former patients wish they had known is that medication decisions work best when they’re collaborative, informed, and realistic. You’re not obligated to start a medication your doctor recommends if, after understanding the full picture—side effects, costs, long-term commitment, and your specific risk factors—it doesn’t align with your life. You also shouldn’t avoid a medication that could genuinely help based on fear of side effects that are rare or manageable. The goal is informed decision-making that accounts for your specific circumstances, values, and priorities.
This approach is especially important in dementia care and cognitive health, where medications might affect not just a single symptom but overall quality of life for both the patient and caregivers. A medication that causes brain fog might not be the right choice for someone in an early stage of cognitive decline, even if it’s effective for the underlying condition. Another patient might find that same medication worthwhile. The difference isn’t the medication—it’s understanding what you’re signing up for and making intentional choices based on that understanding.
Conclusion
Former patients consistently identify a few key themes in what they wish they had known: side effects are often more common and persistent than minimally mentioned, mental health and cognitive changes deserve more attention than they typically receive, cost barriers are real and worth discussing openly, and many medications represent ongoing commitments rather than time-limited treatments. None of these revelations should frighten you away from beneficial medication, but all of them should inform your decision-making process and your conversations with healthcare providers. Moving forward, approach medication conversations as a genuine dialogue where you’re an equal participant. Ask questions that matter to your life.
Share concerns about cost, side effects, and long-term commitment. Request information about the most common and meaningful side effects rather than an overwhelming list or almost no information. If something doesn’t feel right once you start a medication, report it rather than assuming you need to suffer through it. The gap between what patients wish they had known and what they were actually told is a communication problem, not an indication that medications are inherently good or bad—it’s a sign that better conversations need to happen before treatment begins.
